Live Breaking News & Updates on Susan fixel

INmune Bio to Participate in Baird's Biotech Discovery Series Webcast on February 13, 2024 Seite 1

06.02.2024 - Boca Raton, Florida, Feb. 06, 2024 (GLOBE NEWSWIRE) -  INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s disease (AD) with XProTM . Seite 1

University-of-florida , Florida , United-states , Boca-raton , Malu-tansey , Susan-fixel , Nasdaq , Inmune-bio-inc , Parkinson-foundation-research-center , Biotech-discovery-series , Susan-fixel-chair , Foundation-research-center

INmune Bio to Participate in Baird's Biotech Discovery Series Webcast on February 13, 2024 -February 06, 2024 at 09:05 am EST

Boca Raton, Florida, Feb. 06, 2024  INmune Bio, Inc.  , a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s disease with.

University-of-florida , Florida , United-states , Boca-raton , Susan-fixel , Inmune-bio , Malu-tansey , Jason-nelson , David-moss , Company-current-reports-on-form , Exchange-commission , Inmune-bio-inc